Sandoz Group AG (CHIX:SDZZ) Short-Term Capital Lease Obligation : CHF47 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Short-Term Capital Lease Obligation?

Sandoz Group AG's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF47 Mil.

Sandoz Group AG's quarterly Short-Term Capital Lease Obligation increased from . 20 (CHF0 Mil) to Dec. 2022 (CHF29 Mil) and increased from Dec. 2022 (CHF29 Mil) to Dec. 2023 (CHF47 Mil).

Sandoz Group AG's annual Short-Term Capital Lease Obligation increased from . 20 (CHF0 Mil) to Dec. 2022 (CHF29 Mil) and increased from Dec. 2022 (CHF29 Mil) to Dec. 2023 (CHF47 Mil).

Sandoz Group AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for Sandoz Group AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Short-Term Capital Lease Obligation Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

Short-Term Capital Lease Obligation

28.88

46.70

Sandoz Group AG Quarterly Data
	Dec22	Dec23
Short-Term Capital Lease Obligation	28.88	46.70

Sandoz Group AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Sandoz Group AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (CHIX:SDZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (CHIX:SDZz) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZNY:USA D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (CHIX:SDZZ) Headlines

No Headlines